New allergy medication on the way, reports say
Cytovance Biologics and Fountain BioPharma Inc. recently announced that they will be teaming up to develop a new antibody-based pharmaceutical to treat allergies. Each company will take on its own aspect of the generation and production of the drug, a true collaborative effort, according to the companies.
The companies are working together to produce FB301, a novel monoclonal antibody (mAb), which is being developed for the treatment of allergy symptoms.
The particular antibody is currently Fountain's flagship development, with researchers believing that it could have a profound affect on the lives of those who suffer from seasonal allergies.
"Cytovance is excited that Fountain has chosen us to support this innovative treatment for Allergy," said Darren Head, President and Chief Executive Officer of Cytovance Biologics. "Our experienced staff and state-of-the-art facilities are prepared to deliver the highest quality of development and manufacturing services for successful completion of this clinical milestone for FB301."
The new drug could be a big game changer for anyone who suffers from seasonal allergies, since it would work the same way that the immune system already does in order to create a better, more natural response to symptoms.
Cytovance was founded in 2003, and is headquartered in Oklahoma City, Oklahoma. Fountain is a Taiwanese biotechnology company focused on the treatment of many diseases, autoimmune diseases and allergic disorders through antibodies.
Until it is fully developed, those who deal with seasonal allergies on a daily basis can use a car cabin air filter to keep pollen from infecting the air in their car. They can also wear a respirator mask while cleaning, which will help to limit their exposure to harmful allergens in the home.
- Could Botox be the cure for your seasonal allergy symptoms?
- Sheraton opens allergy-friendly hotel in Southern California
- Meth-resistant allergy drugs to hit the market soon
- Drug manufacturer looks to have ban lifted on over-the-counter inhalers
- Alabama the latest state to control cold medication prescriptions